<b>Hybrid "CPA + RevShare" usually underperforms pure RevShare by month 6</b>

<b>Hybrid "CPA + RevShare" usually underperforms pure RevShare by month 6</b>
The popular hybrid — a reduced CPA ($90) plus a reduced RevShare (20%) — is marketed as "best of both." Modeled across ~20 deals, it's frequently the worst of both.

The structure: operators cut both legs roughly in half. So you get half the upfront certainty and half the long-tail compounding.

Worked example, $40 NGR/month player, 9% monthly churn:
— Pure CPA $180: $180 total.
— Pure RevShare 35%: ~$168 by month 12, still climbing.
— Hybrid $90 + 20%: $90 + ~$96 = ~$186 by month 12 — narrowly ahead, but only if churn stays under 9%.

The break: at 12%+ monthly churn the hybrid's RevShare leg starves and it falls behind pure CPA. Hybrid only wins in the narrow band of moderate churn and patient cash flow.

Benchmark of the day: hybrid beats both pure structures only when monthly churn sits in the ~7-10% band and you can wait 6+ months — outside that window, pick a side.